Brendan Knapp MD
Head & Neck Cancer, Thoracic Cancer
PGY6 Hematology Oncology Fellow, Washington University School of Medicine in St. Louis
Join to View Full Profile
660 Euclid AveSaint Louis, MO 63110
Phone+1 314-362-5000
Dr. Knapp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Brendan Knapp, MD, is a hematology and oncology fellow based in Saint Louis, MO. He completed his medical education at Indiana University School of Medicine in 2019, followed by a residency in Internal Medicine and a fellowship in Hematology and Medical Oncology at Washington University/BJH/SLCH Consortium, concluding in 2022. Dr. Knapp is currently serving as a Clinical Fellow at Washington University in St. Louis School of Medicine. His research focuses on various aspects of thoracic and head and neck oncology, including small cell lung cancer and bone metastases.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2022- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2019 - 2022
Indiana University School of MedicineClass of 2019
Purdue UniversityBS, Biology, 2011 - 2015
Certifications & Licensure
MO State Medical License 2019 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 6 citationsThe changing landscape of small cell lung cancer.Giordano Fabricio Cittolin-Santos, Brendan Knapp, Bharath Ganesh, Feng Gao, Saiama Waqar
Cancer. 2024-07-15 - 4 citationsOutcomes in Patients with Spinal Metastases Managed with Surgical Intervention.Brendan Knapp, Ashwin Govindan, Shalin S Patel, Kymberlie Pepin, Ningying Wu
Cancers. 2024-01-19 - 3 citationsIncidence and risk factors for bone metastases at presentation in solid tumors.Brendan J Knapp, Giordano F Cittolin-Santos, Mary E Flanagan, Nikhil Grandhi, Feng Gao
Frontiers in Oncology. 2024-01-01
Abstracts/Posters
- Posttreatment DSC-MRI is Predictive of Early Treatment Failure in Children with Supratentorial High-Grade Glioma Treated with ErlotinibLucas Jr, J. T., Knapp, B. J., Uh, J., Hua, C. H., Merchant, T. E., Hwang, S. N., & Broniscer, A, Radiological Society of North America Annual Meeting, Chicago, Illinois, 11/30/2017
Professional Memberships
- American College of PhysiciansMember
- American Medical AssociationMember
- Indiana State Medical AssociationMember
- Alpha Omega Alpha Honors SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
